Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 500

1.

NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

Berliner JL, Fay AM, Cummings SA, Burnett B, Tillmanns T.

J Genet Couns. 2013 Apr;22(2):155-63. doi: 10.1007/s10897-012-9547-1. Epub 2012 Nov 28.

PMID:
23188549
[PubMed - indexed for MEDLINE]
2.

Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization.

Levy DE, Garber JE, Shields AE.

J Gen Intern Med. 2009 Jul;24(7):822-8. doi: 10.1007/s11606-009-1009-6. Epub 2009 May 20.

PMID:
19455369
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.

American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins--Gynecology; ACOG Committee on Genetics; Society of Gynecologic Oncologists.

Obstet Gynecol. 2009 Apr;113(4):957-66. doi: 10.1097/AOG.0b013e3181a106d4.

PMID:
19305347
[PubMed - indexed for MEDLINE]
4.

Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.

Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ; Society of Gynecologic Oncologists Education Committee.

Gynecol Oncol. 2007 Nov;107(2):159-62.

PMID:
17950381
[PubMed - indexed for MEDLINE]
5.

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.

Horsman D, Wilson BJ, Avard D, Meschino WS, Kim Sing C, Plante M, Eisen A, Howley HE, Simard J; National Hereditary Cancer Task Force.

J Obstet Gynaecol Can. 2007 Jan;29(1):45-60.

PMID:
17346477
[PubMed - indexed for MEDLINE]
6.

[Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD].

Schmutzler R, Schlegelberger B, Meindl A, Gerber WD, Kiechle M; Hereditary Breast- and Ovarian Cancer Consortium, German Cancer AiD.

Zentralbl Gynakol. 2003 Dec;125(12):494-506. German.

PMID:
14755360
[PubMed - indexed for MEDLINE]
7.

Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee.

Eisinger F, Alby N, Bremond A, Dauplat J, Espié M, Janiaud P, Kuttenn F, Lebrun JP, Lefranc JP, Pierret J, Sobol H, Stoppa-Lyonnet D, Thouvenin D, Tristant H, Feingold J.

Ann Oncol. 1998 Sep;9(9):939-50.

PMID:
9818066
[PubMed - indexed for MEDLINE]
Free Article
8.

Breast-cancer risk in families with mutations in PALB2.

Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkäs K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittomäki K, Moilanen JS, Turnbull C, Seal S, Mannermaa A, Kallioniemi A, Lindeman GJ, Buys SS, Andrulis IL, Radice P, Tondini C, Manoukian S, Toland AE, Miron P, Weitzel JN, Domchek SM, Poppe B, Claes KB, Yannoukakos D, Concannon P, Bernstein JL, James PA, Easton DF, Goldgar DE, Hopper JL, Rahman N, Peterlongo P, Nevanlinna H, King MC, Couch FJ, Southey MC, Winqvist R, Foulkes WD, Tischkowitz M.

N Engl J Med. 2014 Aug 7;371(6):497-506. doi: 10.1056/NEJMoa1400382.

PMID:
25099575
[PubMed - indexed for MEDLINE]
9.

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.

Silva FC, Lisboa BC, Figueiredo MC, Torrezan GT, Santos EM, Krepischi AC, Rossi BM, Achatz MI, Carraro DM.

BMC Med Genet. 2014 May 15;15:55. doi: 10.1186/1471-2350-15-55.

PMID:
24884479
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population.

Noh JM, Choi DH, Baek H, Kim MJ, Park H, Huh SJ, Park W, Nam SJ, Lee JE, Kil WH, Haffty BG.

Cancer Genet. 2014 Apr;207(4):160-3. doi: 10.1016/j.cancergen.2014.04.002. Epub 2014 Apr 12.

PMID:
24853100
[PubMed - indexed for MEDLINE]
11.

Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.

Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek CJ.

Am J Surg Pathol. 2014 Jun;38(6):729-42. doi: 10.1097/PAS.0000000000000199.

PMID:
24820399
[PubMed - indexed for MEDLINE]
12.

BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks.

Willis NA, Chandramouly G, Huang B, Kwok A, Follonier C, Deng C, Scully R.

Nature. 2014 Jun 26;510(7506):556-9. doi: 10.1038/nature13295. Epub 2014 Apr 28.

PMID:
24776801
[PubMed - indexed for MEDLINE]
13.

Serous tubal intraepithelial carcinoma in a Japanese woman with a deleterious BRCA1 mutation.

Ishikawa H, Kiyokawa T, Utsuno E, Matsushita K, Nomura F, Shozu M.

Jpn J Clin Oncol. 2014 Jun;44(6):597-601. doi: 10.1093/jjco/hyu035. Epub 2014 Apr 9.

PMID:
24719479
[PubMed - indexed for MEDLINE]
14.

Clinical interpretation and implications of whole-genome sequencing.

Dewey FE, Grove ME, Pan C, Goldstein BA, Bernstein JA, Chaib H, Merker JD, Goldfeder RL, Enns GM, David SP, Pakdaman N, Ormond KE, Caleshu C, Kingham K, Klein TE, Whirl-Carrillo M, Sakamoto K, Wheeler MT, Butte AJ, Ford JM, Boxer L, Ioannidis JP, Yeung AC, Altman RB, Assimes TL, Snyder M, Ashley EA, Quertermous T.

JAMA. 2014 Mar 12;311(10):1035-45. doi: 10.1001/jama.2014.1717.

PMID:
24618965
[PubMed - indexed for MEDLINE]
15.

[Hereditary ovarian carcinomas: clinico-biological features and treatment].

Floquet A, Stoeckle E, Croce S, Longy M, Mc Grogan G, Barouk E, Bubien V, Garbay D, Joly E, Guyon F.

Bull Cancer. 2014 Feb;101(2):167-74. doi: 10.1684/bdc.2014.1888. Review. French.

PMID:
24555961
[PubMed - indexed for MEDLINE]
16.

Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2.

Jackson SA, Davis AA, Li J, Yi N, McCormick SR, Grant C, Fallen T, Crawford B, Loranger K, Litton J, Arun B, Vande Wydeven K, Sidani A, Farmer K, Sanders M, Hoskins K, Nussbaum R, Esserman L, Garber JE, Kaklamani VG; Northwestern Cancer Genetics Group.

Cancer. 2014 May 15;120(10):1557-64. doi: 10.1002/cncr.28577. Epub 2014 Feb 12.

PMID:
24522996
[PubMed - indexed for MEDLINE]
17.

'BRCAness' and its implications for platinum action in gynecologic cancer.

Muggia F, Safra T.

Anticancer Res. 2014 Feb;34(2):551-6. Review.

PMID:
24510983
[PubMed - indexed for MEDLINE]
18.

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.

Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang AT, Chang Y, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Kinney AY, Luta G, Kelleher S, Leventhal KG, Vegella P, Tong A, King L.

J Clin Oncol. 2014 Mar 1;32(7):618-26. doi: 10.1200/JCO.2013.51.3226. Epub 2014 Jan 21.

PMID:
24449235
[PubMed - indexed for MEDLINE]
19.

Familial pancreatic cancer: genetic advances.

Rustgi AK.

Genes Dev. 2014 Jan 1;28(1):1-7. doi: 10.1101/gad.228452.113. Review.

PMID:
24395243
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Staging, risk assessment and screening of breast cancer.

Yalcin B.

Exp Oncol. 2013 Dec;35(4):238-45. Review.

PMID:
24382431
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk